The Use of a Recombinant DNA-based Hyaluronidase to Dissolve Fixed Amounts of Hyaluronic Acid Dermal Fillers
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether or not Recombinant DNA-based hyaluronidase
(RDNAH/Hylenex recombinant), is safe and effective for dissolving hyaluronic acid (HA) dermal
fillers.